The abnormal increase in the activity of the PI3K/Akt/mTOR pathway is associated with various malignancies; therefore, the modulation of this signaling pathway represents a new strategy, in particular in gastric cancer treatment [21]. This evidence concerns the gene AKT1 and gastric cancer.